Assessing cancer drug combination efficacy across 900+PRISM cell lines in a multiplexed screening assay

被引:0
|
作者
George, Ashish Bino
Nair, Shiker
Kocak, Mustafa
Nguyen, Ellen
Kalathungal, Alvin
Fazio, Anthony
Ponsi, Cole
Golabi, Aydin
Ronan, Melissa A.
Rees, Matthew G.
Roth, Jennifer A.
机构
关键词
D O I
10.1158/1538-7445.AM2024-4560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4560
引用
收藏
页数:2
相关论文
共 50 条
  • [31] A high-throughput drug combination screen of targeted small molecule inhibitors in cancer cell lines
    Flobak, Asmund
    Niederdorfer, Barbara
    Nakstad, Vu To
    Thommesen, Liv
    Klinkenberg, Geir
    Laegreid, Astrid
    SCIENTIFIC DATA, 2019, 6 (1)
  • [32] A high-throughput drug combination screen of targeted small molecule inhibitors in cancer cell lines
    Åsmund Flobak
    Barbara Niederdorfer
    Vu To Nakstad
    Liv Thommesen
    Geir Klinkenberg
    Astrid Lægreid
    Scientific Data, 6
  • [33] Determining drug inhibition profiles and opportunities for synergistic combination therapies in head and neck cancer cell lines
    Zoergiebel, Johanna
    Kundu, Abir
    Braegelmann, Johannes
    Shen, Wanda
    El Dinah, Mohamed
    Salgia, Ravi
    Seiwert, Tanguy
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [34] Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines
    Eschenbrenner, Julia
    Winsel, Sebastian
    Hammer, Stefanie
    Sommer, Anette
    Mittelstaedt, Kevin
    Drosch, Michael
    Klar, Ulrich
    Sachse, Christoph
    Hannus, Michael
    Seidel, Monika
    Weise, Bertram
    Merz, Claudia
    Siemeister, Gerhard
    Hoffmann, Jens
    FRONTIERS IN ONCOLOGY, 2011, 1
  • [35] In vitro screening of five Hainan plants of Polyalthia (Annonaceae) against human cancer cell lines with MTT assay
    Yuan, Yuan
    Huang, Guo-jun
    Wang, Tian-shan
    Chen, Guang-ying
    JOURNAL OF MEDICINAL PLANTS RESEARCH, 2011, 5 (05): : 837 - 841
  • [36] Author Correction: Drug screening of cancer cell lines and human primary tumors using droplet microfluidics
    Ada Hang-Heng Wong
    Haoran Li
    Yanwei Jia
    Pui-In Mak
    Rui Paulo da Silva Martins
    Yan Liu
    Chi Man Vong
    Hang Cheong Wong
    Pak Kin Wong
    Haitao Wang
    Heng Sun
    Chu-Xia Deng
    Scientific Reports, 9
  • [37] Glutathione-associated enzymes in the human cell lines of the national cancer institute drug screening program
    Tew, KD
    Monks, A
    Barone, L
    Rosser, D
    Akerman, G
    Montali, JA
    Wheatley, JB
    Schmidt, DE
    MOLECULAR PHARMACOLOGY, 1996, 50 (01) : 149 - 159
  • [38] Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin-Dipyridamole Combination Treatment in Melanoma Cell Lines
    Irie, Nanami
    Mizoguchi, Kana
    Warita, Tomoko
    Nakano, Mirai
    Sasaki, Kasuga
    Tashiro, Jiro
    Osaki, Tomohiro
    Ishikawa, Takuro
    Oltvai, Zoltan N.
    Warita, Katsuhiko
    BIOMEDICINES, 2024, 12 (03)
  • [39] CHARACTERISTICS OF THE COMBINATION PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER CELL-LINES ANALYZED WITH THE ATP-CELL VIABILITY ASSAY
    KOECHLI, OR
    SEVIN, BU
    PERRAS, JP
    CHOU, TC
    ANGIOLI, R
    STEREN, A
    UNTCH, M
    AVERETTE, HE
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 28 (01) : 21 - 27
  • [40] STUDYING INDIVIDUAL DIFFERENCES IN CANCER DRUG EFFICACY USING CELL LINES DERIVED FROM PATIENTS.
    Hankemeier, T.
    Kaddurah-Daouk, R.
    Koval, V. V.
    Harms, A. C.
    Moon, I.
    Kuwahara, H.
    Bos, S.
    Marin, S.
    Cascante, M.
    Weinshilboum, R.
    Wang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S103 - S103